Again, the combined treatment with TKI and ABT-737 did have more impact on reducing progenitor population in primary CML cells with the BIM deletion polymorphism when compared to those without. Here, BCL2L11 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.